#chemotherapy

• Adjuvancy — The property, quality, or mode of action of a therapeutic factor or substance to assist, support, or intensify the effect of a primary treatment. In clinical oncology, the term describes the strategy of administering secondary systemic therapies (chemotherapy, radiotherapy, hormone therapy) after the complete surgical removal of the primary tumor.
• Anticancer — Combating, preventing, or destroying malignant tumor cells; an oncological substance, cellular therapy, or cytostatic medication specially designed to halt neoplasm proliferation within the human organism. In a modern clinical sense, the term covers classic chemotherapy molecules as well as advanced immunotherapy protocols and molecularly targeted therapies.
• Anti-cancer — Fighting against neoplasms, preventing the progression of malignant tumors, or destroying cancerous tissues in the organism; synonymous with anticarcinogenic and anticancer, utilized to describe the therapeutic effect of certain drugs, chemotherapeutic regimens, or oncological medical campaigns.
• Antileukemic — Combating, destroying, or halting the proliferation of cancerous cells specific to leukemia; a chemotherapeutic drug, cytostatic agent, or molecular therapy utilized in the treatment of malignant disorders of the hematopoietic system. In a clinical sense, it acts structurally by inhibiting the division of abnormal blastic cells in the bone marrow and restoring normal blood cell production.
• Antimetabolite — A natural or synthetic chemical substance whose molecular structure closely resembles that of an essential metabolite in the body, capable of blocking, competing with, or inhibiting its normal utilization in cellular processes; in a clinical sense, it is used in chemotherapy (such as methotrexate or fluorouracil) to sabotage DNA synthesis in tumor cells.
• Antimitotic — Preventing, blocking, or halting mitosis (the process of indirect cell division); a chemotherapeutic medication, cytostatic agent (such as vinca alkaloids or taxanes) utilized in the treatment of malignant tumors. In a clinical sense, it acts structurally by disrupting or excessively stabilizing the mitotic spindle, halting the uncontrolled multiplication of cancer cells.
• Antineoplastic — Preventing the development, proliferation, or multiplication of malignant tumor cells; a cytostatic or chemotherapeutic medication, or a biological agent utilized in cancer treatment. In a clinical and molecular sense, it intervenes structurally in cellular metabolism, blocking DNA replication or disrupting the mitotic spindle to induce cancer cell apoptosis.
• Antitumor — Preventing, combating, inhibiting, or destroying the development and proliferation of tumors, especially malignant ones; a medication, chemotherapeutic agent, or biological agent used in cancer therapy. These compounds act by blocking abnormal cell division, inducing apoptosis in cancer cells, or halting the angiogenesis necessary for the tumor's nutrition.
• Antiemetic — Preventing, combating, soothing, or stopping the sensation of nausea and the act of vomiting; a medication or active substance (such as metoclopramide or ondansetron) administered in the treatment of digestive disorders, motion sickness, or to counteract the emetic side effects of chemotherapy. These compounds act either centrally, by blocking dopaminergic or serotonergic receptors in the brain, or peripherally, by regulating the motility of the gastrointestinal tract.